» Articles » PMID: 32280814

Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade Gliomas

Abstract

Purpose: To review and critique the current state of liquid biopsy in pHGG.

Materials And Methods: Published literature was reviewed for articles related to liquid biopsy in pediatric glioma and adult glioma with a focus on high-grade gliomas.

Results: This review discusses the current state of liquid biomarkers of pHGG and their potential applications for liquid biopsy development.

Conclusions: While nascent, the progress toward identifying circulating analytes of pHGG primes the field of neuro-oncoogy for liquid biopsy development.

Citing Articles

Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.

Ronsley R, Karvonen K, Cole B, Paulson V, Stevens J, Crotty E J Neurooncol. 2024; 168(2):215-224.

PMID: 38755519 DOI: 10.1007/s11060-024-04645-y.


Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas.

Fernando D, Ahmed A, Williams B Front Oncol. 2024; 14:1347694.

PMID: 38525424 PMC: 10957575. DOI: 10.3389/fonc.2024.1347694.


Liquid biopsy and tumor DNA/RNA detection in the cerebrospinal fluid of patients diagnosed with central nervous system glioma - A review article.

Borba L, Passos G, Oliveira I Surg Neurol Int. 2023; 14:183.

PMID: 37292399 PMC: 10246314. DOI: 10.25259/SNI_52_2023.


Tumor-Educated Platelets: A Review of Current and Potential Applications in Solid Tumors.

Varkey J, Nicolaides T Cureus. 2021; 13(11):e19189.

PMID: 34873529 PMC: 8635758. DOI: 10.7759/cureus.19189.

References
1.
Staedtke V, Dzaye O, Holdhoff M . Actionable molecular biomarkers in primary brain tumors. Trends Cancer. 2017; 2(7):338-349. PMC: 5461965. DOI: 10.1016/j.trecan.2016.06.003. View

2.
Sullivan J, Nahed B, Madden M, Oliveira S, Springer S, Bhere D . Brain tumor cells in circulation are enriched for mesenchymal gene expression. Cancer Discov. 2014; 4(11):1299-309. PMC: 4221467. DOI: 10.1158/2159-8290.CD-14-0471. View

3.
Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K . Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014; 9(4):e92921. PMC: 3976275. DOI: 10.1371/journal.pone.0092921. View

4.
Stone M, Frendel E . The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Am J Med. 1975; 58(5):601-19. DOI: 10.1016/0002-9343(75)90496-9. View

5.
Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View